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and edge dissections. METHODS A total of 84 patients were prospectively randomized to ACR-guided
PCI, OCT-guided PCI (without co-registration), and angiography-guided PCI. Primary endpoint was a
composite of major edge dissection and/or LGM as assessed by post-PCI OCT. RESULTS The primary
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p = 0.03) and angiography-guided PCI (25.5%; p < 0.01). Rates of LGM were 4.2%, 17.0%, and 22.9%
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and without significant differences among the study groups (0% vs. 2.1% vs. 4.3%). CONCLUSION This
study for the first time demonstrates superiority of ACR-guided PCI over OCT- and angiography-guided
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Abstract
Aims Longitudinal geographic mismatch (LGM) as well as edge dissections are associated with an increased risk of adverse 
events after percutaneous coronary intervention (PCI). Recently, a novel system of real-time optical coherence tomography 
(OCT) with angiographic co-registration (ACR) became available and allows matched integration of cross-sectional OCT 
images to angiography. The OPTICO-integration II trial sought to assess the impact of ACR for PCI planning on the risk 
of LGM and edge dissections.
Methods A total of 84 patients were prospectively randomized to ACR-guided PCI, OCT-guided PCI (without co-registra-
tion), and angiography-guided PCI. Primary endpoint was a composite of major edge dissection and/or LGM as assessed 
by post-PCI OCT.
Results The primary endpoint was significantly reduced in ACR-guided PCI (4.2%) as compared to OCT-guided PCI 
(19.1%; p = 0.03) and angiography-guided PCI (25.5%; p < 0.01). Rates of LGM were 4.2%, 17.0%, and 22.9% in the ACR-
guided PCI, in the OCT-guided PCI, and the angiography-guided PCI groups, respectively (ACR vs. OCT p = 0.04; ACR 
vs. angiography p = 0.04). The number of major edge dissections was low and without significant differences among the 
study groups (0% vs. 2.1% vs. 4.3%).
Conclusion This study for the first time demonstrates superiority of ACR-guided PCI over OCT- and angiography-guided PCI 
in reducing the composite endpoint of major edge dissection and LGM, which was meanly driven by a reduction of LGM.
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Abbreviations
ACR  Angiographic co-registration
CCR  Chronic coronary syndrome
DES  Drug-eluting stents
eGFR  Estimated creatinine clearance
IQR  Interquartile range
IVUS  Intravascular ultrasound
LGM  Longitudinal geographic mismatch
LVEF  Left ventricular ejection fraction
MLA  Minimal lumen area
MSA  Minimal stent area
OCT  Optical coherence tomography
PCI  Percutaneous coronary interventions
QCA  Quantitative coronary angiography
STE-ACS  ST-segment elevation acute coronary 
syndromes
Introduction
Percutaneous coronary intervention (PCI) has become stand-
ard therapy for chronic coronary syndrome (CCS) [1] and 
shows favorable results using third-generation drug-elut-
ing stents (DES) [2]. However, previous studies revealed 
residual disease at the stent edge—termed as longitudinal 
geographic mismatch (LGM)—and stent edge dissections 
to be associated with an increased risk for major adverse 
cardiac events (MACE) after PCI [3]. Optical-coherence-
tomography (OCT)-guided PCI may reduce these complica-
tions by allowing a more detailed pre-procedural coronary 
lesion evaluation [3–6]. However, the use of OCT in this 
setting is limited by difficulties in matching cross-sectional 
OCT images to angiography, i.e., translating the optimal 
stent landing zone from OCT to angiography. Recently, a 
system for real-time co-registration of OCT images with 
angiography (ACR = angiographic co-registration) became 
available [7]. This technique may overcome these limitations 
and, therefore, strengthen the use of OCT for PCI planning. 
Recently, the OPTICO-Integration-I trial demonstrated, that 
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ACR had significant impact on the selected PCI strategy, 
particularly in complex lesions [8]. However, the efficacy 
of ACR to improve PCI results as compared to OCT- and 
angiographic-guided PCI has never been evaluated.
Therefore, the “Impact of Real-time Angiographic Co-
registered OCT on PCI Results” (OPTICO-Integration-II 
trial; NCT03646097) trial was designed as a prospective, 
randomized pilot study to evaluate the effect of ACR guided 
PCI compared to OCT- and angiographic-guided PCI on the 
incidence of LGM and/or stent edge dissections after PCI.
Methods
Study design
The OPTICO-Integration-II trial was a prospective, single-
center, randomized, open label trial. Consecutive patients 
undergoing coronary angiography were screened for suit-
ability at the Charité—University Medicine Berlin, Ger-
many, between August 2017 and July 2018. Subjects were 
considered eligible when angiography revealed significant 
coronary artery disease (based on visual assessment in at 
least one native coronary artery together with a positive 
ischemia test in stable coronary artery disease or lesions 
causing acute coronary syndromes) [9]. Exclusion crite-
ria comprised in-stent restenosis, ST-segment elevation 
acute coronary syndromes (STE-ACS), cardiogenic shock, 
left ventricular ejection fraction (LVEF) < 30%, estimated 
creatinine clearance (eGFR) < 40  ml/min, neoplasia on 
treatment or without a curative therapeutic approach, life 
expectancy < 24 months, pregnancy, participation in another 
investigational clinical trial, as well as inability or unwilling-
ness to give written informed consent. Furthermore, lesions 
unsuitable for OCT imaging were excluded, such as severely 
calcified or extremely tortuous vessels, as well as very distal 
lesions or a reference vessel diameter of > 4 mm or < 2 mm. 
Finally, patients were randomly assigned in a 1:1:1 ratio to 
either ACR (group I), OCT (group II) or angiography-guided 
PCI (group III). Permuted block randomization with vari-
able block size was performed by means of sealed opaque 
envelopes containing a computer-generated sequence. Ran-
domization was conducted after crossing the target lesion 
with the coronary guidewire.
The study was approved by the local Ethics Commit-
tee at Charité—University Medicine Berlin, Germany 
(EA1/072/17) and was registered at ClinicalTrials.gov 
(NCT03646097). Written informed consent was obtained 
from all participating subjects.
OCT and procedural details
For OCT imaging the OPTIS™ integrated system (St. Jude 
Medical, St. Paul, MN) with Dragonfly™ Duo (St. Jude 
Medical, St. Paul, MN, USA) catheters were used. After 
placement of a standard 0.014 inch coronary guidewire 
over a 6F guiding catheter and injection of 200 mg of intra-
coronary nitroglycerin an automatic OCT pullback was 
performed with a contrast flush  (IMERON® 350; Bracco 
Imaging Deutschland GmbH, Konstanz, Germany) using an 
automated power injector. OCT images covering the stenotic 
area and at least 10 mm of the vessel segments proximal and 
distal to the lesion and were recorded with an axial resolu-
tion of 200 μm.
For study groups I (ACR) and II (OCT), the OCT scan 
was immediately evaluated by the operator using the regu-
lar OCT acquisition console (OPTIS™ integrated system): 
In group I (ACR) the commercially available semi-auto-
matic co-registration OPTIS™ integrated system was used 
for co-registration of coronary angiography and OCT [7]. 
This results in a matched side-by-side view of angiogra-
phy and OCT was available for the operator, with a small 
white marker projected over the angiogram and indicating 
the exact localization (error margin about 1 mm [7]) of the 
displayed OCT frame on the angiogram. However, in study 
groups I (ACR) and II (OCT), operators were encouraged 
to choose a stent-landing zone, which ensures optimal target 
lesion coverage defined as untreated minimal lumen area 
(MLA) ≤ 60% of the adjacent reference segment lumen area 
up to 10 mm from the proximal and distal stent edges [5]. 
Furthermore, vessel-wall characteristics as plaque load were 
taken into account for selection of the optimal stent-landing 
zone. Stent size selection included assessment of the rela-
tion to the reference vessel size. Importantly, PCI optimiza-
tion in the ACR and OCT group followed the ILUMIEN 
IV—OPTIMAL PCI OCT criteria (NCT03507777). Stent 
optimization in the angiography-guided PCI group was 
performed at the discretion of the operator. Details of the 
PCI strategy including need for pre-dilation, special lesion 
debarking, vessel reference diameter, intended lesion and 
stent length, intended stent diameter, intended stenting strat-
egy and device landing zone were documented in every case.
After angiography-based stent optimization PCI results 
were documented by OCT in all three study groups to assess 
the primary study endpoint. After primary study endpoint 
evaluation, further post-PCI optimization was allowed 
based on the final OCT in all study groups according to 
individual operator‘s estimation. All OCT scans were post-
hoc analyzed by an independent OCT core lab blinded for 
the randomization group using an external OCT analysis 
console (OPTIS™, St. Jude Medical, St. Paul, MN, USA) 
and performing Quantitative coronary angiography (QCA) 
for all lesions among the three study groups. Only very 
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experienced operators (n = 5; > 1000 PCIs lifelong) were 
involved in this trial.
Endpoints
The primary study endpoint was a composite imaging 
endpoint including major edge dissections and/or LGM as 
assessed by post-procedural OCT. Major edge dissections 
were defined as each dissection with flap angle ≥ 60° of the 
circumference of the vessel at the site of dissection and/
or ≥ 3 mm in length after PCI according to the ILUMIEN 
IV—OPTIMAL PCI OCT criteria (NCT03507777). Longi-
tudinal geographic mismatch (LGM) was defined as every 
untreated plaque with a minimal lumen area < 4.5mm2 within 
5 mm of the reference segment. If the segment of the lesion 
was fully covered and the stent protruded maximal 5 mm 
beyond the predetermined landing zone in the post-PCI OCT 
analysis it was considered as no geographic mismatch, again 
in line to ILUMIEN IV criteria. Secondary study endpoints 
included each individual component of the primary endpoint 
as well as the incidence of any edge dissection (any visible 
edge dissection < 60 degrees of the circumference of the ves-
sel and < 3 mm in length), stent underexpansion [proximal 
minimal stent area (MSA) < 90% of the proximal reference 
lumen area, and/or distal MSA < 90% of the distal reference 
lumen area] and stent malapposition (stent struts separated 
from the vessel wall with a distance from the adjacent intima 
of ≥ 0.2 mm and not associated with any side branch). Fur-
thermore, PCI result was assessed by determining MSA, 
length of the stented segment, number of implanted stents, 
as well as procedure time, fluoroscopy time, contrast volume 
and complications during hospital stay.
Statistical analysis
Sample size calculation was based on a retrospective evalu-
ation of OCT-guided PCI cases (n = 350) within the Charite 
University Medicine Berlin using a system without ACR, 
where LGM was detectable in 35% and additional major 
edge dissections in 5% of all PCI cases. Under the assump-
tion that a combined imaging endpoint including major edge 
dissections and/or LGM is detectable in 35% of the segments 
with OCT-guided PCI and can be markedly reduced to 5% 
of patients by ACR-guided PCI, a total of 48 patients (24 
per group) yield a power of 80% (with a 2-sided α = 0.05) 
to detect a difference in the primary endpoint between 
Fig. 1  Study flow. Due to image quality issues some stent edges were 
not assessable in the respective groups of the trial. For the final analy-
sis, a total of 48 stent edges in the ACR group, 47 stent edges in the 
OCT group and 47 stent edges in the angiography group were avail-
able for primary endpoint analysis. OCT denotes optical coherence 
tomography
Table 1  Baseline characteristics of the study cohort (n = 84)
Data are expressed as median (IQR) or n (%).OCT denotes optical 
coherence tomography
ACR angiographic co-registration; PAD peripheral artery disease; 
CAD coronary artery disease; ACS acute coronary syndrome, PCI 
percutaneous coronary intervention, and LDL low-density lipoprotein
Clinical characteristics Total study cohort n = 84





Family history of CAD 50.0% (42)
Obesity 21.4%(18)
PAD 7.1% (6)
Prior ACS 32.1% (27)
Serum-Creatinine, mg/dl 1.0 (0.9–1.1)
Total Cholesterol, mg/dl 157 (131–191)
LDL, mg/dl 91 (69–128)
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patients with ACR-guided (study group I) and OCT-guided 
PCI (study group II). Furthermore, an equal group (n = 24) 
who underwent angiography-guided PCI (study group III) 
was included as an additional control group. Anticipating a 
drop-out rate of 12%—again based on retrospective image 
analysis at the study center—a total of 84 patients were con-
sidered sufficient. Given the fact that the primary endpoint 
can occur twice per patient, at the proximal and the distal 
stent edge, an edge-based analysis was performed to assess 
differences regarding the endpoints between groups.
All data were analyzed according to the intention-to-treat 
principle. Categorical variables were expressed as numbers 
and percentages, and continuous variables as means and 
standard deviation or medians and interquartile range (IQR). 
Categorical variables were assessed by the Chi square test 
or the Fisher’s exact test as appropriate. Continuous vari-
ables were tested for normal distribution using the Kolmogo-
rov–Smirnov test with Lilliefors correction, and group com-
parisons were performed using the Kruskal–Wallis tests or 
analysis of variance (ANOVA). Stent-edge based compari-
sons among the three study groups were performed using 
multilevel mixed-effects logistic regression. All variables 
that were significant in univariate analysis were entered into 
the multivariate model. A p value of 0.05 was considered 
statistically significant. All statistical analyses were per-
formed by SPSS Version 22 (IBM Corp., Armonk, USA).
Results
Baseline characteristics
Of 198 screened patients, a total of 84 patients were included 
and randomly assigned to undergo PCI guided by ACR 
(group I), OCT (group II) or angiography only (group III). 
The study flow is described in Fig. 1. A total of 14 patients 
were excluded due to impossibility for OCT imaging 
Table 2  Lesion characteristics
*Lesion within true bifurcations (diameter side branch > 2.5). Data are expressed as median (IQR) or n (%). OCT denotes optical coherence 
tomography
ACR angiographic co-registration
Angio-guided n = 28 OCT-guided n = 28 ACR-guided n = 28 p for trend
Diameter stenosis, % 55.65 (51.05–67.60) 63.10 (59.10–66.50) 55.50 (48.30–67.35) 0.50
Minimal lumen diameter, mm 0.95 (0.80–1.10) 1.00 (0.80–1.30) 1.10 (0.90–1.30) 0.98
Lesion length, mm 17.25 (12.20–25.80) 17.90 (15.75–26.75) 18.40 (12.35–25.15) 0.54
Reference vessel diameter, mm 2.86 (2.51–3.23) 2.95 (2.61–3.27) 2.97 (2.35–3.36) 0.92
ACC/AHA-Type B2/C lesion 71.4% (20) 64.3% (18) 64.3% (18) 0.81
Bifurcation lesions* 25.0% (7) 28.6% (8) 25.0% (7) 0.94
Fig. 2  Primary endpoint of the composite consisting of major edge 
dissections and/or LGM. The primary endpoint was significantly 
lower in ACR group (4.2%, n = 2) compared to the OCT group 
(19.1%, n = 9, p = 0.03) and angiography group (25.5%, n = 12, 
p < 0.01). No significant difference was observed between the OCT 
and angiography group (p = 0.46). The light blue columns represent 
the incidence of longitudinal geographic mismatch. The middle blue 
columns represent the incidence of both longitudinal geographic mis-
match and major edge dissection. The dark blue columns represent 
the incidence of major edge dissection. ACR denotes angiographic 
co-registration; LGM longitudinal geographic mismatch; OCT optical 
coherence tomography
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(pre-PCI = 2; post-PCI = 4) or low OCT imaging quality 
(pre-PCI = 3; post-PCI = 5). Baseline clinical characteris-
tics are presented in Table 1. The population was predomi-
nantly male and characterized by a high prevalence of type 
2 diabetes. Lesion characteristics (Table 2) were comparable 
among groups. Diameter stenosis as assessed by QCA was 
similar in the respective groups.
Table 3  Incidence of primary and secondary study endpoints among the study groups
Data are expressed as median (IQR) or n (%)
Stent struts clearly separated from the vessel wall without any tissue behind the struts with a distance from the adjacent intima of ≥ 0.2 mm and 
not associated with any side branch
2 Optimal—MSA/Reference segment lumen area = ≥ 95%; acceptable—MSA/Reference segment lumen area =  ≥ 90% and < 95%
OCT denotes optical coherence tomography; ACR angiographic co-registration; LGM longitudinal geographical mismatch; MSA minimal stent 
area
*Not estimated because of small event numbers
# Instead of odds ratio regression coefficient given
Angio-guided 
n = 47 stent 
edges
OCT-guided 
n = 47 stent 
edges
ACR-guided 
n = 48 stent 
edges
Angio vs. OCT ACR vs. OCT ACR vs. Angio





25.5% (12/47) 19.1% (9/47) 4.2% (2/48) 1.45 (0.54–3.85) 0.46 0.18 (0.04–0.90) 0.03 0.13 (0.03–0.60)  < 0.01
Secondary endpoints
 LGM 22.9% (11/48) 17.0% (8/47) 4.2% (2/49) 1.45 (0.52–4.00) 0.47 0.21 (0.04–0.98) 0.04 0.14 (0.03–0.69) 0.02
 Major edge 
dissection
4.3% (2/47) 2.1% (1/47) 0.0% (0/48) 2.04 (0.18–23.34) 0.57 –* –* –* –*
 Any edge 
dissection
25.5% (12/47) 17.4% (8/47) 0.0% (0/48) 1.63 (0.60–4.45) 0.34 –* –* –* –*
 Malapposi-
tion1
60.0% (30/50) 62.5% (30/48) 58.3% (28/48) 0.90 (0.28–2.87) 0.86 0.84 (0.26–2.70) 0.77 0.93 (0.30–2.94) 0.91
 MSA proxi-
mal,  mm2#
5.3 (4.3–7.0) 6.2 (5.4–7.6) 6.6 (4.4–7.6) 0.15 (− 0.72–2.20) 0.32 0.14 (− 0.80–2.07) 0.87  − 0.13 (− 1.04–0.31) 0.58
 MSA distal, 
 mm2#





62.5% (30/48) 68.0% (34/50) 82.6% (38/46) 0.78 (0.24–2.57) 0.69 2.24 (0.56–8.85) 0.25 2.85 (0.73–11.19) 0.13
Table 4  Procedural characteristics among the three study groups
Data are expressed as median (IQR) or n (%). OCT denotes optical coherence tomography
ACR angiographic co-registration








Procedure duration, min 53 (38–73) 49 (43–62) 49 (39–59 0.87 0.22 0.27
Fluoroscopy duration, min 13.67 (10.92–17.63) 14.05 (8.33–19.70) 13.73 (8.67–17.98) 0.98 0.80 0.79
Radiation dose, mGy 774.0 (525.0–895.0) 625.0 (442.5–894.0) 650 (381.5–885.5) 0.38 0.74 0.23
Contrast volume, ml 213.5 (160.0–248.0) 200.0 (165.0–246.0) 196.5 (159.0–222.5) 0.61 0.23 0.09
Stents per lesion 2 (1–2) 1 (1–2) 1 (1–2) 0.14 0.78 0.05
Max. stent diameter, mm 3.0 (2.75–3.5) 3.0 (3.0–3.5) 3.0 (2.5–3.5) 0.28 0.54 0.90
Stent length, mm 28 (18–38) 28 (23–35) 26 (18–33) 0.52 0.19 0.61
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Primary endpoint
The primary endpoint was significantly reduced by ACR-
guided PCI (4.2%, n = 2) as compared to OCT-guided PCI 
(19.1%, n = 9, p = 0.03) and angiography-guided PCI (25.5%, 
n = 12, p < 0.01) (Fig. 2, Table 3). There was no significant 
difference between OCT- and angiography- guided PCI 
(p = 0.46).
Secondary endpoints
Other predefined secondary endpoints are reported in 
Table 3. The incidence of LGM was significantly reduced 
with ACR- (4.2%) as compared to OCT- (17.0%; p = 0.04) 
and angiography-guided PCI (22.9%; p = 0.02). Major edge 
dissections affected the proximal edge in 13.9% of the 
cases and the distal edge in 14.3% of the cases. Whereas 
OCT-guided PCI was associated with reduced rates of any 
edge dissections after PCI as compared to angiography-
guided PCI (17.4% vs. 25.5%; p = 0.34), no edge dissection 
was detectable after ACR-guided PCI. Malapposition as 
defined in this study occurred in 60.0%, 62.5% and 58.3% 
without a statistically significant difference, respectively. 
The stent results with respect to MSA and stent expansion 
were comparable among the three study groups (Table 3). 
This was also true for procedural characteristics (Table 4) 
as numbers of implanted stents, stent length, radiation 
exposure, amount of contrast medium and procedural time 
did not differ among groups (Table 4). Finally, in-hospital 
clinical complications were observed in two patients, one 
in the OCT (repeat coronary angiography due to recurrent 
chest pain) and one in the angiography group (acute coro-
nary syndrome).
Predictors of longitudinal geographic missmatch 
and/or major edge dissection
Neither age, type 2 diabetes, nor acute coronary syndrome as 
index event or high lesion complexity (AHA class B2/C) was 
identified as significant predictors for the incidence of LGM 
or major edge dissections after PCI (Table 5). Importantly, 
the use of ACR- as compared to OCT-guided PCI [OR 0.17 
(0.03–0.93); p = 0.04] as well as compared to angiographic-
guided PCI [OR 0.12 (0.02–0.66); p = 0.02] was found to be 
inversely related with the primary endpoint (Table 5).
Discussion
The OPTICO-integration II trial demonstrated for the first 
time a significant lower incidence of LGM and/or major 
edge dissections for ACR-guided PCIs as compared to an 
OCT- or angiography-guided approach.
Intracoronary imaging techniques revealed favorable 
results in terms of MACE as compared to angiography-
guided PCI [10–12]. However, most of these studies inves-
tigated intravascular ultrasound (IVUS) and focused on stent 
optimization for complex coronary lesions [10–12]. Due to 
the limited axial resolution, especially in diffusely diseased 
calcified lesions, IVUS allows for advanced vessel sizing, 
without, however, providing detailed information on plaque 
composition and vessel-wall characteristics. Optical coher-
ence tomography as a novel intracoronary high-resolution 
imaging technology with a tenfold increased axial resolu-
tion as compared to IVUS allows for more comprehensive 
lesion assessment. Its effect on PCI results as well as poten-
tial clinical benefits remains unknown. Recently, few clinical 
studies evaluating the effect of OCT guidance during PCI 
and including systematic OCT analysis during the phase of 
PCI planning were published [3, 5, 6, 13]. However, none of 
these studies specifically analyzed the implication of OCT-
guided PCI planning on stent results [3, 5, 6, 13]. Not sur-
prisingly, the incidence of untreated lesions in the reference 
segment was similar between OCT- and angiography-guided 
PCI in ILUMIEN III [5].
Since matching of the cross-sectional OCT images to 
the angiography by ACR became available [7], the opti-
mal stent landing zone identified by OCT can be accurately 
translated to angiography during stent placement. A recent 
study demonstrated that ACR significantly changed the ini-
tial PCI strategy in almost half of the procedures, thereby 
improving the rate of complete lesion coverage, especially 
in complex coronary artery lesions prone to adverse events 
after PCI, e.g., diffusely diseased vessel segments or when 
precise stent deployment may be hampered due to missing 
anatomical landmarks [8].
Table 5  Independent predictors on the primary combined study end-
point of LGM and/or major edge dissection
ACR denotes angiographic co-registration
OCT optical coherence tomography; PCI Percutaneous coronary 
intervention; ACS acute coronary syndrome and ACC/AHA Ameri-
can College of Cardiology/American Heart Association
Incidence of LGM and/or 
major edge dissection
OR 95% CI p value
Angiographic vs. OCT-guided PCI 1.36 (0.49–3.75) 0.55
ACR-guided PCI vs. OCT-guided PCI 0.17 (0.03–0.93) 0.04
ACR-guided PCI versus Angio-
graphic-guided PCI
0.12 (0.02–0.66) 0.02
Age 1.00 (0.96–1.05) 0.83
Diabetes mellitus 0.97 (0.33–2.84) 0.96
PCI within ACS-setting 0.40 (0.03–5.13) 0.48
ACC/AHA-Type B2/C lesion 1.83 (0.55–6.09) 0.32
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In addition to a modification of the in PCI strategy by 
ACR, the current OPTICO-integration II trial for the first 
time demonstrates significantly improved PCI results by 
ACR with lower rates of LGM and edge dissections after 
PCI. A recent OCT study revealed incomplete lesion cov-
erage after angiography-guided PCI in about 70% of the 
investigated lesions [14]. When real-time ACR was used, 
the frequency of LGM decreased by fivefold to less than 
5% as this novel fusion imaging tool allowed for an exact 
localization of the intended stent landing zone compared 
to 17% longitudinal geographical mismatch in the OCT 
group without co-registration [14]. ACR guidance allows 
for an easy applicable and replicable correlation between 
the OCT-detected borders of the coronary lesion and its 
cross-sectional angiographic correlation [7], which empha-
sizes precise lesion coverage as revealed by the dramatically 
reduced LGM rate in this study. However, as stent length did 
not differ between ACR-, OCT- and angiography-guided PCI 
in this study, which is in line with other studies [5], the lower 
risk of LGM related to ACR may be explained mainly by a 
more accurate targeting of the stent landing zone rather than 
an extended lesion coverage.
Previous OCT studies identified high vulnerable plaque 
burden and severe circumferential calcifications at the stent 
edge as predictors of edge dissections after PCI [15, 16]. 
In the present study, stent edge dissection could be com-
pletely avoided when ACR was used, as compared to 17.4% 
when OCT-guidance was performed during PCI planning. 
Therefore, ACR may optimize stent sizing – including cover-
age of vulnerable plaques within the edges of the coronary 
lesions and optimal stent-positioning outside a vulnerable 
plaque to avoid incident edge dissections [16]. In a recent 
trial comparing ACR- with OCT-guided PCI, although no 
differences were observed in terms of LGM (27.6% with 
ACR vs. 34.0% with OCT; p = 0.33), a 50%-reduction in 
the risk of distal stent edge dissection after ACR-guided 
PCI was observed similar to this study [17]. Differences 
between the studies may at least in part be due different 
patient populations included and differences in the study 
protocols. In the present study, the primary endpoint was 
recorded immediately after achieving an angiographic opti-
mal PCI result as compared to endpoint assessment after 
additional PCI-optimization by OCT or ACR, respectively, 
which may result in more frequent optimization procedures 
including additional stenting in case of inacceptable lesion 
coverage for OCT-guided PCI and consequently equalize 
potential differences between groups achieved by ACR [17].
Significant edge dissections after PCI [18] have been 
reported to be associated with a twofold increased risk of 
MACE [18–20] and likewise LGM is known to be a driver 
for target vessel revascularization and adverse events [21]. 
The large “Clinical Impact of OCT Findings During PCI” 
(CLI-OPCI II) trial pointed out a fivefold increased risk 
of MACE by uncovered residual plaques after PCI [3]. 
Although the present study was not designed and powered 
to detect differences in clinical outcomes, complete lesion 
coverage with simultaneously significant reduced rates of 
major edge dissections as achieved by ACR may positively 
affect procedural outcomes after PCI.
Several limitations need to be noted. Despite adequate 
patient size calculation and powering for the imaging end-
point in the present study, the total number of included 
patients is relatively low and allows no evaluation of poten-
tial impact on clinical endpoints. Furthermore, the present 
study is a single-center trial with all known limitations of 
this trial design. Since investigator blinding was not possible 
due to the study design, PCI results may have been influ-
enced by operators’ individual preference and experience. 
However, an independent and blinded corelab analysis was 
performed to minimize this bias. The participating operators 
gained large experience regarding OCT-guided procedures 
in daily practice, which might influence OCT handling (e.g., 
correct and effective performance of OCT pullbacks) and 
stent implantation technique with respect to avoidance of 
PCI-related complications. This may explain the missing dif-
ference in contrast volume among the groups und low rate of 
edge dissections in all three study groups compared to other 
studies [5]. Moreover, endpoint analysis was based on the 
ILUMIEN IV-OPTIMAL PCI OCT-criteria. Investigators 
were trained for using these criteria in their OCT-guided 
PCI, which are considered the state-of-the-art of OCT guid-
ance. However, the ongoing ILUMIEN IV- OPTIMAL PCI 
trial has yet to prove whether this approach has an impact 
on clinical outcomes.
Conclusions
The OPTICO-integration II trial evaluated the effect of real-
time optical coherence tomography co-registration with 
angiography on PCI results and demonstrated a significant 
reduction in the composite primary endpoint of LGM and/or 
major edge dissection—both relate with adverse outcomes 
following PCI—as compared to OCT- as well as to angiog-
raphy-guided PCI, which was meanly driven by a reduction 
of LGM. The clinical value of this finding needs to be inves-
tigated in clinical outcome trials.
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